Regeneron agrees to $270m extension to supply Ebola medicine in US
The arrangement builds on a partnership with BARDA within the US Department of Health and Human Services.
Drug Development
China’s NMPA accepts Innovent application for sintilimab combo
Lunit and Summit to evaluate pathology platform for tumour analysis
Pathos AI completes $237m Series E round to expand oncology pipeline
Boehringer and Microsoft collaborate to explore AI in clinical research
Celltrion and Kaigene sign $580m licence deal for KG013
Astellas and AI Proteins sign miniprotein therapeutics deal
MSD’s Keytruda and Padcev combination receives EC approval
